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eurotransmitter release requires the direct coupling of
the calcium sensor with the machinery for membrane
fusion. SNARE proteins comprise the minimal fusion
machinery, and synaptotagmin I, a synaptic vesicle protein,
is the primary candidate for the main neuronal calcium
sensor. To test the effect of synaptotagmin I on membrane
fusion, we incorporated it into a SNARE-mediated liposome
fusion assay. Synaptotagmin I dramatically stimulated
membrane fusion by facilitating SNAREpin zippering.
Ñ
 
This stimulatory effect was topologically restricted to v-SNARE
vesicles (containing VAMP 2) and only occurred in trans
to t-SNARE vesicles (containing syntaxin 1A and SNAP-25).
Interestingly, calcium did not affect the overall fusion re-
action. These results indicate that synaptotagmin I can
directly accelerate SNARE-mediated membrane fusion
and raise the possibility that additional components
might be required to ensure tight calcium coupling.
 
Introduction
 
Interneuronal communication and information processing in
the brain is mediated by the quantal release of neurotrans-
mitters triggered by the influx of calcium into the nerve
terminal. These calcium-induced events occur on the sub-
millisecond timescale, thus suggesting that the calcium sensor
is tightly coupled to the machinery that fuses neurotransmitter-
containing synaptic vesicles with the plasma membrane.
SNAREs, a family of compartment-specific transmembrane
proteins, initiate membrane fusion when a v-SNARE on a
transport vesicle pairs with its cognate t-SNARE on the
target membrane, forming SNAREpins (trans SNARE
complexes) (Söllner et al., 1993; Weber et al., 1998). In
the case of neurotransmitter release, the synaptic vesicle-
bound v-SNARE VAMP 2 interacts with its cognate t-SNARE,
consisting of syntaxin 1 and SNAP-25, on the presynaptic
plasma membrane. Subsequent stepwise SNARE assembly
into a four helix bundle brings the two membranes in close
apposition and drives lipid bilayer mixing (Sutton et al.,
1998; Weber et al., 1998; Nickel et al., 1999; Chen et al.,
2001). Regulatory components, such as the calcium sensor,
may alter the kinetics of SNARE complex assembly at distinct
stages by trapping or accelerating reaction intermediates.
The prime candidate for a calcium sensor in the central
nervous system is synaptotagmin I, a type I transmembrane
protein localized on synaptic vesicles (Brose et al., 1992;
Südhof and Rizo, 1996). Gene deletions of synaptotagmin
I in 
 
Mus musculus
 
, 
 
Caenorhabditis elegans
 
, and 
 
Drosophila
melangaster
 
 all demonstrate a marked loss of calcium-
evoked fusion (Littleton et al., 1993; Nonet et al., 1993;
Broadie et al., 1994; Geppert et al., 1994). In addition,
replacement of endogenous synaptotagmin I in mice with
a mutant version that has a twofold lower affinity for calcium
in the presence of phospholipid membranes causes a con-
comitant decrease in the calcium sensitivity of neurotransmitter
release (Fernández-Chacon et al., 2001). These results
provide compelling in vivo evidence that synaptotagmin
I is the major calcium sensor for fast synaptic exocytosis.
At the molecular level, synaptotagmin I is characterized
by two conserved cytoplasmic calcium-binding domains,
C2A and C2B, which interact in a calcium-dependent
manner with the synaptic t-SNAREs, acidic lipids, and
phosphoinositides (Bennett et al., 1992; Brose et al., 1992;
Schiavo et al., 1996, 1997; Davis et al., 1999; Gerona et
al., 2000; Earles et al., 2001). In addition, the C2B do-
main of synaptotagmin I is responsible for the homo- and
heterooligomerization of synaptotagmins (Osborne et al.,
1999; Desai et al., 2000) of which there are 13 known
mammalian isoforms (Kelly, 1995; Augustine, 2001; Südhof,
2002). Recent electrophysiological studies of dense core
vesicle fusion in PC12 cells have shown that overexpres-
sion of synaptotagmins with different calcium affinities
differentially modulate fusion pore kinetics (Wang et al., 2001).
These experiment further link synaptotagmin I to the actual fu-
sion process.
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Despite strong evidence that synaptotagmin I couples cal-
cium sensitivity to vesicle fusion, the molecular mechanisms
by which it acts remain elusive. Two main hypotheses exist
about how synaptotagmin I might regulate membrane fu-
sion: (1) synaptotagmin I acts as a clamp, preventing fusion
of docked vesicles until an influx of calcium releases the
clamp, and (2) synaptotagmin I stimulates fusion upon the
influx of calcium. In addition, there are variations of these
models that require additional components to control cal-
cium-triggered exocytosis (Kelly, 1995).
Deconvolution of the mechanism of action of synaptotag-
min I in vivo has been hindered by the degeneracy of synap-
totagmin isoforms and the difficulty of separating the molec-
ular functions of synaptotagmin I from those of other
accessory proteins in the complex cellular environment. Thus,
we used a simplified in vitro model of membrane fusion that
allowed us to examine the role of synaptotagmin I in a de-
fined and accessible system (Weber et al., 1998). This ap-
proach has been used previously to establish that SNAREs are
the minimal machinery for membrane fusion (Weber et al.,
1998) and to show that SNARE-mediated fusion is specific
and topologically restricted (Fukuda et al., 2000; McNew et
al., 2000; Parlati et al., 2000). In addition, this assay has dem-
onstrated that the NH
 
2
 
-terminal regulatory domain (NRD)*
of syntaxin I not only regulates t-SNARE assembly but also
effects SNAREpin formation (Parlati et al., 2000). However,
the relatively slow fusion kinetics of the in vitro system, in
comparison with those of regulated exocytosis in vivo, indi-
cate that additional components may be required to accelerate
the overall reaction. In this article, we test the effect of synap-
totagmin I on SNARE-mediated fusion, and we examine its
putative regulatory roles using the in vitro fusion assay.
 
Results
 
Sytg I reconstituted into v-SNARE vesicles accelerates 
SNARE-dependent fusion
 
We monitored membrane fusion using a fluorescent reso-
nance energy transfer–based lipid mixing assay (Struck et
al., 1981). Briefly, when two fluorescent lipids, nitro-2,1,3-
benzoxadiazole 1,2-dipalmitoyl-SN-glycero-3 (NBD)–phos-
phatidylethanolamine (PE) and lissamine rhodamine B
1,2-dipalmitoyl-SN-glycero-3–PE (rhodamine-PE) are in-
corporated at appropriate concentrations (0.8 mol%) into
donor vesicles, the fluorescence signal emitted by NBD-PE
is quenched by rhodamine-PE. Fusion of the labeled donor
vesicles with unlabeled acceptor vesicles dilutes the fluores-
cent lipids causing a distance-dependent increase in NBD-
PE fluorescence over time. Finally, the NBD signal is nor-
malized to the maximum fluorescence signal obtained by
infinite dilution in the presence of detergent and plotted as the
percentage of the total fluorescence versus time. In the fol-
lowing experiments, VAMP 2 (v-SNARE) was reconstituted
into labeled donor liposomes, and coexpressed syntaxin 1
and SNAP-25 (t-SNAREs) were incorporated into unla-
beled acceptor liposomes (Weber et al., 1998).
 
To facilitate synaptotagmin I expression and reconstitu-
tion into liposomes, we used a modified NH
 
2
 
-terminal trun-
cated synaptotagmin I (Sytg I), which begins at aa 57 (see
Material and methods for details). Donor liposomes con-
taining reconstituted VAMP 2, VAMP 2 and Sytg I (Sytg
I–VAMP 2), and Sytg I alone (Fig. 1 A) were prepared using
standard protocols (Weber et al., 2000). These liposomes
were mixed with acceptor t-SNARE liposomes in the pres-
ence of buffer or the cytosolic domain of VAMP 2 (cd–
VAMP 2) without any calcium addition, and the fusion
activity was monitored for 2 h at 37
 
 
 
C. Sytg I–VAMP 2
liposomes showed a remarkable increase in fusion activity when
compared with liposomes containing only VAMP 2 (Fig. 1
B). Sytg I enhanced the fusion kinetics of VAMP 2 lipo-
somes in a dose-dependent manner as demonstrated by the
increased initial fusion rates (Fig. 1 C). At the highest con-
centration of Sytg I there is an approximate twofold excess
of Sytg I over t-SNARE on a liposome to liposome basis.
However, there is twofold more VAMP 2 than Sytg I in the
v-SNARE liposomes, and the total amount of t-SNARE in
the fusion assay is sixfold higher than Sytg I. For technical
reasons, we could not incorporate more Sytg I without low-
ering the amount of VAMP 2 molecules, thus the observed
fivefold stimulation of the initial fusion rate by synaptotag-
min I must be considered as a minimal number. Soluble cd–
VAMP 2 inhibited the stimulatory effect of Sytg I, con-
firming that the observed membrane fusion is SNARE
dependent (Fig. 1 B). Furthermore, liposomes containing
Sytg I but lacking VAMP 2 did not fuse with t-SNARE lipo-
somes, although Sytg I interacts with t-SNAREs (Fig. 1 B and
see Fig. 6 B) (Gerona et al., 2000). These results clearly
show that synaptotagmin I by itself does not have any fuso-
genic activity and that the cross-linking of liposomes via Sytg
I–t-SNARE binding interactions is insufficient to induce fusion.
 
Soluble cd–Sytg I stimulates SNARE-dependent fusion
 
One possible explanation for the effect of Sytg I on fusion is
that the t-SNARE binding activity of Sytg I potentiates vesi-
cle binding, and therefore, the stimulatory effect on fusion is
simply a consequence of the additional docking sites pro-
vided by Sytg I. To determine if this is the case, we con-
structed a cytosolic domain of synaptotagmin I (cd–Sytg I)
that started immediately after the transmembrane region at
aa 82. Notably, this construct differs from previously pub-
lished soluble constructs, which start at aa 95 or 96 (Davis et
al., 1999; Osborne et al., 1999). We then studied the ability
of cd–Sytg I to accelerate fusion in an assay that is more sen-
sitive to stimulatory components. For this purpose, we incor-
porated t-SNAREs into labeled donor liposomes and VAMP
2 into unlabeled acceptor liposomes. In addition, we reduced
the amount of VAMP 2 incorporated into the acceptor lipo-
somes 
 
 
 
15-fold compared with the standard assay. This re-
duces the number of copies of VAMP 2 per liposome from
 
 
 
375 in the standard assay to 
 
 
 
25 in the modified assay, a
number comparable to the VAMP 2 concentration in synap-
tic vesicles (Jahn and Südhof, 1994; Weber et al., 1998).
The low concentration of v-SNAREs incorporated into
the acceptor liposomes resulted in no observable fusion in
the absence of cd–Sytg I within the 2-h incubation period
(Fig. 2). However, the addition of 9 
 
 
 
M cd–Sytg I signifi-
 
*Abbreviations used in this paper: NBD, nitro-2,1,3-benzoxadiazole
1,2-dipalmitoyl-SN-glycero-3;
 
 
 
NRD, NH
 
2
 
-terminal regulatory domain;
PE, phosphatidylethanolamine. 
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cantly stimulated fusion. This stimulation was SNARE de-
pendent, since it was inhibited by the presence of cd–VAMP
2. It should be noted that the overall concentration of syn-
aptotagmin I in this assay is 
 
 
 
10 fold higher and the ratio of
synaptotagmin to t-SNARE is 
 
 
 
30-fold higher than in the
fusion assay shown in Fig. 1 B. A Sytg I construct starting at
aa 95 gave similar results when added to the fusion assay
(unpublished data). We also tested the membrane-spanning
Sytg I construct in this modified assay and found compara-
ble results to those seen in the standard assay (unpublished
data). In summary, both the membrane anchored Sytg I and
its cytosolic domain stimulated fusion. Our results using the
cytosolic domain of synaptotagmin I exclude the possibility
that the stimulatory effect is merely due to the presence of
additional vesicle docking sites.
 
The stimulatory effect of Sytg I on fusion is 
topologically restricted
 
Given that synaptotagmin I, which is localized on synaptic
vesicles, cycles through the plasma membrane after exocyto-
sis, Sytg I might also stimulate fusion when localized at the
plasma membrane. To test this possibility, we reconstituted
Sytg I into t-SNARE–containing unlabeled acceptor lipo-
somes, which represent the plasma membrane in our assay
 
for 2 h at 37
 
 
 
C, and the results were normalized to the maximum NBD 
fluorescence signal after addition of detergent (dodecylmaltoside). 
(C) Dose-dependent stimulation of fusion by Sytg I. Donor liposomes 
containing a constant amount of VAMP 2 but increasing amounts of 
Sytg I were incubated with acceptor t-SNARE liposomes, and the 
fusion was monitored and analyzed as described. Linear regression 
analysis (Cricket Graph III, curve fit) was performed using the first 
eight data points (first 14 min), and the initial rate of fusion (
 
 
 
 % 
total fluorescence/
 
 
 
 time) was plotted against the total amount of
reconstituted Sytg I–VAMP 2.
Figure 1.
 
Incorporation of Sytg I into labeled VAMP 2 liposomes 
accelerates fusion. 
 
(A) Reconstituted donor liposomes. Donor 
liposomes containing VAMP 2 alone (lane 1), Sytg I–VAMP 2 (lane 2), 
and Sytg I alone (lane 3) were analyzed by SDS-PAGE and stained 
with Coomassie blue. The positions of VAMP 2 and Sytg I are 
marked by arrows. (B) Fusion in the presence of Sytg I. Unlabeled 
acceptor liposomes (45 
 
 
 
l) containing syntaxin 1A/SNAP 25 (t-SNARE) 
were prewarmed to 37
 
 
 
C and mixed at time 
 
  
 
0 with prewarmed 
donor liposomes (5 
 
 
 
l) labeled with rhodamine and NBD lipids in 
the presence and absence of the cytosolic domain of VAMP 2 
(cd–VAMP 2, aa 1–94, added in approximately equimolar amounts 
to the t-SNARE). The increase in NBD fluorescence was monitored 
Figure 2. Soluble cd–Sytg I accelerates SNARE-dependent fusion. 
Unlabeled acceptor liposomes (45  l) containing VAMP 2 were 
prewarmed to 37 C and mixed at time   0 with prewarmed labeled 
donor liposomes (5  l) containing t-SNARE in the presence and 
absence of the cytosolic domain of Sytg I (cd–Sytg I,  10  M final 
concentration) and cd–VAMP 2 (see Fig. 1B legend). Note that in 
assays treated with cd–VAMP 2, the donor liposomes were pretreated 
with cd–VAMP 2 for 15 min before their mixing with acceptor 
liposomes. The increase in NBD fluorescence was monitored, and 
the results were normalized as before. 
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(Fig. 3 A). In this topological arrangement, Sytg I did not
stimulate the fusion reaction (Fig. 3 B), suggesting that the
cis configuration of synaptotagmin I and t-SNARE does not
allow a productive interaction. Thus, synaptotagmin I stim-
ulates fusion only when present in trans to the t-SNARE
(i.e., in the opposite membrane to the t-SNARE), demon-
strating that the appropriate localization of Sytg I is crucial
to its ability to enhance fusion.
 
Sytg I accelerates fusion-committed docking
 
To further understand how Sytg I regulates fusion, we ana-
lyzed the effect of Sytg I on different stages of the overall re-
action. In the in vitro fusion assay, the following steps can be
resolved (Fig. 4 A). First, t-SNARE complex activation in-
volves the functional removal of the NH
 
2
 
-terminal domain
of syntaxin 1A (NRD; Fig. 4 A) (Parlati et al., 1999). Subse-
quently, SNAREpins are formed between liposomes and
“zip up” into a partially assembled helical bundle. This reac-
tion is initially reversible and then becomes resistant to treat-
ment with cd–VAMP 2 and neurotoxins (Weber et al.,
1998; Melia et al., 2002). Low temperature (4
 
 
 
C) blocks
membrane fusion allowing us to accumulate these SNARE-
pin intermediates (Weber et al., 1998). Finally, lipid bilayers
fuse, and SNAREpins are fully assembled into cis-SNARE
complexes in which membrane-spanning regions reside in
the same membrane and their cytoplasmic domains form a
“fully zipped up” four helical bundle.
To test whether the stimulatory effect of synaptogmin I is
comparable to that caused by the removal of NH
 
2
 
-terminal
domain of syntaxin 1A, we used a t-SNARE construct contain-
ing syntaxin 1A with a thrombin-cleavable NH
 
2
 
-terminal do-
main (N–t-SNARE) (Parlati et al., 1999). Acceptor liposomes
containing N–t-SNARE were prepared and treated with either
thrombin (tc–N–t-SNARE) or AEBSF-inactivated thrombin
(N–t-SNARE) immediately before addition into the fusion as-
say. As expected, cleavage of the NH
 
2
 
-terminal domain of syn-
taxin 1 increased the fusion efficiency in presence of VAMP 2
liposomes (Fig. 4 B) (Parlati et al., 1999). However, when the
fusion kinetics of VAMP 2, tc-N–t-SNARE liposomes were
compared with those of Sytg I–VAMP 2, N–t-SNARE lipo-
somes, we observed that the NRD removal has a much less
prominent effect than that caused by Sytg I (Fig. 4 B). Further-
more, cleavage of the inhibitory NH
 
2
 
-terminal domain of syn-
taxin 1A did not further enhance the initial kinetics of Sytg
I–VAMP 2 liposome fusion, although it modestly increased the
final fusion signal (Fig. 4 B). These results indicate that synap-
totagmin I has a function that exceeds the mere removal of the
NRD of syntaxin 1A and suggests a role in facilitating a later
stage of SNARE complex assembly.
To examine if Sytg I affects the rate of SNARE assembly
between liposomes, we captured docked complexes at 4
 
 
 
C
(Weber et al., 1998) in the presence and absence of Sytg I
and tested at which time they become resistant to the addi-
tion of cd–VAMP 2. This assay measures how far SNARE-
pin assembly has proceeded and indicates the time at which
docked liposomes become fusion committed. Donor lipo-
somes containing either VAMP 2 alone or Sytg I–VAMP 2
were incubated with acceptor t-SNARE liposomes at 4
 
 
 
C for
varying amounts of time before cd–VAMP 2 was added
(Fig. 5 A). All reactions were kept on ice until the final time
point when the reactions were warmed to 37
 
 
 
C and fusion
was allowed to take place. Liposomes containing Sytg I at-
tained a fusion-committed docked state much faster than li-
posomes without Sytg I (Fig. 5, C and B, respectively). In
fact, after only 1 h at 4
 
 
 
C Sytg I–VAMP 2 liposomes display
the same signal that VAMP 2 liposomes attain after an over-
night incubation. In contrast to VAMP 2 liposomes, which
have a basal fusion activity of 5% of the total fusion signal at
4
 
 
 
C overnight, Sytg I–VAMP 2 liposomes showed an in-
creased fusion potential at this low temperature (16% of the
total fusion signal [unpublished data]). Thus, we conclude
that Sytg I promotes the formation of fusion-committed
SNAREpins. It may also catalyze SNARE-mediated mem-
brane mixing, but that distinction is hard to make without
the ability to examine individual fusion events.
Figure 3. Sytg I reconstituted into t-SNARE liposomes does not 
accelerate fusion. (A) Acceptor liposomes containing t-SNARE (lane 1) 
or Sytg I and t-SNARE (lane 2) were analyzed by SDS-PAGE and 
stained with Coomassie blue. The positions of syntaxin 1A, SNAP 
25, and Sytg I are marked by arrows. (B) Acceptor liposomes (45  l) 
were prewarmed to 37 C and mixed at time   0 with prewarmed 
labeled donor liposomes (5  l) containing VAMP 2. The increase in 
NBD fluorescence was monitored, and the results were normalized 
as before. 
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The stimulatory effect of Sytg I is calcium independent
 
So far, our experiments indicate that Sytg I stimulates fusion
in absence of external calcium. However, since synaptotag-
min I is the prime candidate for a neuronal calcium sensor,
we analyzed the effect of calcium on the fusion reaction in
the presence of Sytg I. To our surprise, neither the addition
of EGTA nor an effective calcium concentration of 
 
 
 
900
 
 
 
M altered our basic results (Fig. 6 A). Compared with
EGTA, calcium reproducibly caused a minor reduction of
the initial fusion kinetics and a small increase in the extent
of final fusion of the Sytg I–containing liposomes; however,
the significance of these minor changes remains to be de-
termined. We confirmed that our Sytg I construct retains
the basic calcium-dependent properties, such as calcium-
dependent liposome binding and oligomerization (unpub-
lished data). We also reexamined the binding of Sytg I to
t-SNARE. Due to the calcium-dependent oligomerization of
the synaptotagmin construct, we prebound Sytg I to protein
A beads using the anti-Sytg monoclonal antibody M48 and
then added t-SNARE in the presence or absence of calcium.
At saturating concentrations of t-SNARE (1 
 
 
 
M), signifi-
cant binding between Sytg I and t-SNARE was observed in
the absence and presence of calcium; however, calcium still
increased the overall interactions (Fig. 6 B). We obtained
similar results with the cd–Sytg I construct starting at aa 82
and with another anti-Sytg monoclonal antibody CI. 41.1
(unpublished data). These results are in agreement with data
previously obtained with full-length native synaptotagmin I
(Chapman et al., 1995b; Gerona et al., 2000). This largely
calcium-independent synaptogamin I–t-SNARE interaction
may provide the basis for the calcium-independent stimula-
tory effect on fusion that we observed.
 
Discussion
 
Synaptotagmin I plays a critical role in calcium-evoked neu-
rotransmitter release, and accumulating evidence indicates
that it functions as the major calcium sensor in neurons.
SNARE complex formation, the process underlying exocy-
tosis, is highly regulated in neuronal systems with synap-
Figure 4. Cleavage of the NH2-terminal domain of syntaxin 1A 
does not effect Sytg I–dependent acceleration. (A) Steps in the in 
vitro fusion assay. First, the NRD (oval) of syntaxin 1A (represented 
here by the medium gray cylinder connected to the oval) moves to 
form an activated t-SNARE complex (SNAP 25 is represented by the 
two connected light gray cylinders). Next, VAMP 2 (single cylinder) 
interacts with the activated complex to form a fusion-competent 
docked SNARE complex. Finally, membrane fusion occurs 
accompanied by formation of the cis-SNARE complex. (B) Kinetic 
profiles of membrane fusion in the presence of Sytg I with t-SNARE 
missing the NRD. Unlabeled acceptor liposomes containing thrombin 
cleavable t-SNARE (N–t-SNARE) were treated with thrombin (tc) or 
buffer (Parlati et al., 1999). Fusion assays were performed as 
described in the Fig. 1 legend. 
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totagmin I forming part of the regulatory machinery. Herein
we demonstrate that synaptotagmin I profoundly accelerates
SNARE mediated membrane fusion in a topologically re-
stricted manner, even in the absence of calcium.
SNARE complex formation in neurons begins with the
controlled formation of the t-SNARE, a process which is neg-
atively regulated by the NRD and other syntaxin binding pro-
teins such as Munc 18-1 (Dulubova et al., 1999; Misura et al.,
2000; Fisher et al., 2001). The NRD block must be released
to allow t-SNARE formation, a process most likely mediated
by a component such as Munc 13 (Betz et al., 1997). In the
process of t-SNARE formation, the NRD block on SNARE-
pin formation seen in our fusion assay is most likely relieved.
After t-SNARE formation on the plasma membrane, SNARE
complexes assemble into a four-helix bundle in a zippering re-
action that may involve multiple steps, a theory supported by
several in vivo studies (Hua and Charlton, 1999; Xu et al.,
1999). SNARE complex formation starts at the membrane-
distal end of the SNARE motif and may be slowed down by
the inherent instability of the membrane-proximal domains of
the t-SNARE (Fiebig et al., 1999; Melia et al., 2002) and the
increasingly repulsive forces between the lipid bilayers. Al-
though membrane fusion will eventually proceed, the rate
may be too slow to ensure fast regulated exocytosis, and addi-
tional components accelerating the reaction may be required
(Weber et al., 1998; Fasshauer et al., 2002).
Our data indicate that synaptotagmin I could be such an
accelerating component. Synaptotagmin I accelerates the
initial rate of fusion at least by a factor of five (Fig. 1 C).
These results are consistent with the recent observation that
synaptotagmin I promotes the assembly of cytoplasmic
SNARE domains in vitro (Littleton et al., 2001). Synap-
totagmin overcomes the block caused by the NRD (Fig. 4
B) and, more significantly, accelerates SNAREpin formation
(Fig. 5). Accordingly, synaptotagmin I converts the initially
reversible SNAREpin into a fusion-committed state that can
no longer be inhibited by the addition of cd–VAMP 2. In
the absence of synaptotagmin I and at low temperatures,
the initial v-liposome–t-liposome interaction occurs within
minutes, but it takes several hours or an overnight incuba-
tion for the reversible SNAREpin interaction to become re-
sistant to neurotoxins or to the inhibitory cytoplasmic do-
main of VAMP 2 (Weber et al., 1998). The latter reaction,
which is greatly enhanced by synaptotagmin I, may involve
the membrane-proximal domain of the t-SNARE. Indeed, it
has been shown that synaptotagmin I interacts with the
membrane-proximal part of the syntaxin 1 SNARE motif
 
Figure 5.
 
Sytg I accelerates fusion-committed docking. 
 
(A) Acceptor 
t-SNARE liposomes (45 
 
 
 
l) were mixed with donor liposomes (5 
 
 
 
l) 
containing VAMP 2 with and without Sytg I at 4
 
 
 
C. After time equals 
x, cd–VAMP 2 (equimolar to t-SNARE) was added, and the reaction 
was allowed to incubate at 4
 
 
 
C until the final time point. The mixture 
was then warmed to 37
 
 
 
C, and the reaction is monitored as described 
in Fig. 1 legend. (B) Kinetic profiles of fusion from a time course of 
functionally docked VAMP 2 liposomes. The assay was performed as 
outlined in A. Note that the normalized data ignores the preassay 
fusion and an initial drop in fluorescence, which is due to temperature 
effects on the fluorescent probes (Chapman et al., 1995a), is typically 
observed. In addition, please note that the time course for SNAREpin 
formation is concentration dependent. (C) Kinetic profiles of fusion 
from a time course of functionally docked VAMP 2–Sytg I liposomes. 
The assay was performed as outlined in A. 
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and the COOH-terminus of SNAP-25 (Chapman et al.,
1995b; Kee and Scheller, 1996; Davis et al., 1999; Gerona
et al., 2000). Induction or stabilization of helical confirma-
tions in these membrane-proximal domains could facilitate
SNAREpin zipping and thereby accelerate fusion. Interest-
ingly, it has been shown that a COOH-terminal VAMP-2
peptide that binds to the membrane-proximal region of the
t-SNARE structures these domains and accelerates fusion
(Melia et al., 2002). Structural analysis of a synaptotagmin
I–t-SNARE complex will be required to understand the re-
action mechanism in detail.
The observed topological restriction of the stimulatory ef-
fect has important physiological consequences (Fig. 3). The
inherent physicochemical properties of synaptotagmin I en-
sure that only the vesicle carrying the calcium sensor is sub-
jected to accelerated fusion and therefore calcium regulation.
In other words, the presence of synaptotagmin I on the
 
plasma membrane would not affect the fusion of vesicles
lacking synaptogamin I (e.g., constitutive transport vesicles),
thus adding an addition level of control over which vesicles
are primed for calcium-dependent fusion.
However, surprisingly the stimulatory effect of synaptotag-
min was calcium independent. At first glance, this result
seems to directly contradict the concept that synaptotagmin I
is either an inhibitory clamp (hypothesis 1) or a calcium-
dependent promoter of fusion (hypothesis 2). Indeed, the stim-
ulatory effect of synaptotagmin I is incompatible with the
clamp hypothesis. However, we cannot completely exclude
that calcium might further stimulate the reaction. After cal-
cium influx into the nerve terminal, the first synaptic vesicle
fuses within less than 1 ms, indicating that SNAREpins
are already preassembled. If synaptotagmin I–accelerated
SNAREpin assembly is the rate-limiting step in our fusion
assay, we would not be able to detect any faster reactions that
may follow. We attempted to overcome this potentially rate-
limiting step by accumulating prefusion intermediates in
presence of synaptotagmin at 4
 
 
 
C and then adding calcium
during the warm-up phase. Even under these conditions we
could not detect a significant stimulatory effect of calcium
(unpublished data). This raises the possibility that synap-
totagmin I and SNAREs alone are not sufficient to mediate
calcium-regulated exocytosis, and additional components,
such as lipids or proteins (perhaps even a different synap-
totagmin isoform), may be required. Indeed, genetic evi-
dence has indicated that additional components are necessary
(Kelly, 1995). In summary, our data demonstrates that syn-
aptogamin I plays an important accelerating role in SNARE-
pin assembly and membrane fusion. Future experiments will
reveal whether the addition of further components to the re-
constituted assay will confer calcium sensitivity.
 
Materials and methods
 
All lipids were from Avanti with the exception of [
 
3
 
H]-1,2-dipalmitoyl
phosphatidylcholine ([
 
3
 
H]-DPPC), which is from Amersham Pharmacia
Biotech. The anti–synaptotagmin I monoclonal antibody CI.41.1 was from
Synaptic Systems.
 
Plasmid constructions
 
Construction of membrane-anchored synaptotagmin I. 
 
The cDNA encoding
full-length synaptotagmin I was amplified by PCR using a rat brain 
 
 
 
-GT11
cDNA library (CLONTECH Laboratories, Inc.) and the following oligonu-
cleotides: (a) GGGGGATCCATGGTGAGTGCCAGTCATCC and (b) GGG-
GAGCTCTTACTTCTTGACAGCCAGCATGG and cloned into PCR-Script
(Stratagene) according to the manufacturer’s instructions. This construct
was digested with PstI and EcoRI, and a double-stranded oligonucleotide of
phosphorylated oligonucleotides (c) GGTAGAGGAGGAGGTTGATGC-
CATGCTGGCTGTCAAGAAGGAGCTCCTCGAGG and (d) AATTCCTC-
GAGGAGCTCCTTCTTGACAGCCAGCATGGCATCAACCTCCTCCTCTAC-
CTGCA was inserted by ligation yielding pTW25, thus removing the stop
codon. The coding sequence for synaptotagmin I was excised by digestion
of pTW25 with NcoI and XhoI. This fragment was ligated into pET-28b
(Novagen) digested with the same enzymes yielding pTW27 encoding full-
length synaptotagmin I with a COOH-terminal his
 
6
 
 tag. To remove the lu-
minal domain, pTW27 was digested with NcoI and KpnI. The PCR product
of oligonucleotides (e) AGATCTCCATGGGTCCGTGGGCCTTAATAGC-
TATAGCCATAGTTGCGGTCC and (f) CTAATTCCGAGTAGGGTACCT-
TGAAAGTAAATTGTTC and template pTW27 was digested with the same
enzymes and then ligated into the cut pTW27 yielding pTW70. This con-
struct encodes synaptotagmin I (under the control of a T7 promoter) with-
out its lumenal domain (aa 1–56) but with a COOH-terminal his
 
6
 
 tag. In
addition, the protein encoded is an isoform in which calcium-dependent
oligomerization is abolished (Desai et al., 2000) and contains an amino
Figure 6. Sytg I–dependent acceleration of SNARE-mediated
fusion is insensitive to calcium. (A) Kinetic profiles of membrane 
fusion of labeled Sytg I–VAMP 2 liposomes with unlabeled t-SNARE 
liposomes with 1 mM EGTA in the presence or absence of 2 mM 
CaCl2. The assay was performed as in the Fig. 1 legend. (B) Binding 
of t-SNARE (Syntaxin 1A/ SNAP 25) to Sytg I. Full-length t-SNARE 
(1  M) was incubated with immobilized Sytg I in the presence of 
either 1 mM EGTA (EGTA) or 1 mM CaCl2 (Ca
2 ). t-SNARE binding 
was assayed by SDS-PAGE and with Coomassie blue staining. 
Controls lacking Sytg I failed to bind to t-SNARE (unpublished data). 
The positions of IgG, Sytg I, syntaxin 1A, and SNAP 25 are marked 
by arrows. 
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acid mutation at aa 188 (Glu to Asp), which correlates to a conserved resi-
due in all other synaptotagmins (note that numbering follows that of the
whole protein as defined in Perin et al. [1990]). To restore calcium-depen-
dent oligomerization, we mutated the aspartate at aa 374 to a glycine resi-
due (Desai et al., 2000) using site-directed mutagenesis (QuikChange kit;
Stratagene) and the following primers: (g) GGCAAGAACGACGCATC-
GGCAAAGTCTTCGTTGGTTAC and (h) GTAACCAACGAAGACTTTGC-
CGATGGCGTCGTTCTTGCC to yield plasmid pLM1.
We then introduced the following mutations into pLM1: (1) Cys 75 to
Ala using primers (a) GTCCTTTTAGTCGTAACCTG GCCTTTTGTGTCTG-
TAAGAAATG and (b) CATTTCTTACAGACACAAAAGGCGCAGGTTAC-
GACTAAAAGGAC, (2) Cys 79 to Ile using primers (a) CCTGCGCCTT-
TTGTGTCATTAAGAAATGTTTGTTC and (b) GAACAAACATTTCTTAAT-
GACACAAAAGGCGCAGG, (3) Cys 82 to Leu using primers (a) CCT-
TTTGTGTCATTAAGAAATTGTTGTTCAAAAAGAAAAAC and (b) GTTTT-
TCTTTTTGAACAACAATTTCTTAATGACACAAAAGG, (4) Cys 74 to Ser
using primers (a) GTCCTTTTAGTCGTAACCTCCGCCTTTTGTGTCAT-
TAAG, and (b) CTTAATGACACAAAAGGCGGAGGTTACGACTAAAAG-
GAC, and (5) Cys 77 to Ser using primers (a) GTCGTAACCTCCGC-
CTTTTCTGTCATTAAGAAATTGTTG and (b) CAACAATTTCTTAATGACA-
GAAAAGGCGGAGGTTACGAC, to yield the final plasmid pLM6 encoding
a synaptotagmin I capable of calcium-dependent oligomerization with no
cysteines in the transmembrane region. These transmembrane domain cys-
teines have been shown to form disulfide bonds in lipid bilayers in vitro
when recombinant protein is used (Bai et al., 2000; Fukuda and Miko-
shiba, 2000). However, this does not correspond to the condition in vivo,
since native synaptotagmin I does not form these disulfide bonds due to
the stoichiometric palmitoylation of these cysteines (Veit et al., 1996; Bai
et al., 2000). Thus, we mutated the cysteines in the transmembrane do-
main to the 
 
C
 
. 
 
elegans
 
 sequence and substituted serine for the two remain-
ing Cys residues (aa 74 and 77) to create pLM6.
 
Construction of cytoplasmic synaptotagmin I plasmids. 
 
To generate a plas-
mid that encodes the cytoplasmic synaptotagmin I domain starting at aa
Cys 82, the pLM1 template and the following primers were used for PCR:
(a) GGGCATATGTGTTTGTTCAAAAAGAAAAACAAGAAGAAGGGGAA-
GGAAAAGGGAGGAAAGAACGC and (b) TTTCTCGAGCTTCTTGACAG-
CCAGCATGGCATCAACCTCCTCCTCTA. The PCR product was digested
with NdeI and XhoI and ligated into the pET 24 vector, which codes for a
COOH-terminal his
 
6
 
 Tag yielding the plasmid pLM7.
The plasmid pLM8, encoding a soluble synaptotagmin I beginning at
Lys 95, was made in an identical manner to pLM7 but with the following
primers: (a) GGGCATATGAAGGGAGGAAAGAACGCCATTAAC and (b)
TTTCTCGAGCTTCTTGACAGCCAGCATGGCATC.
 
Protein expression and purification
 
To obtain Sytg I, pLM6 was transformed into BL21 DE3 pLysS tuner cells
(Novagen). The cells of 1 liter of overnight preculture in superbroth con-
taining 50 
 
 
 
g/ml kanamycin and 35 
 
 
 
g/ml chloramphenicol were used to
start 4 
 
 
 
 2–liter cultures in superbroth containing 50 
 
 
 
g kanamycin. The
cultures were induced with 0.5 mM IPTG when an optical density (OD
 
600
 
nm) of 0.8 was reached. After 3 h, the bacteria were sedimented by centrif-
ugation, washed once in D-PBS (2.67 mM KCl, 1.47 mM KH
 
2
 
PO
 
4
 
, 138
mM NaCl, 8.10 mM Na
 
2
 
HPO
 
4 
 
· 7H
 
2
 
0), and resuspended in breaking buffer
(25 mM Hepes · KOH, pH 7.4, 400 mM KCl, 5 mM 
 
 
 
-mercaptoethanol, 1
mM MgCl
 
2
 
, 0.01 mM CaCl
 
2
 
, 10% glycerol). To this cell suspension was
added a protease inhibitor cocktail (final concentrations: 1.2 
 
 
 
g/ml leu-
peptin, 2 
 
 
 
g/ml antipain, 20 
 
 
 
g/ml turkey trypsin inhibitor, 10 
 
 
 
g/ml benz-
amidine, 5 
 
 
 
g/ml pefabloc SC, 8.2 TIC/L aprotinin, 5 
 
 
 
g/ml chymostatin,
2.5 
 
 
 
g/ml pepstatin) and 1/4 vol 20% (wt/vol) Triton X-100. The suspen-
sion was then passed three times through an Avestin cell disrupter at
 
 
 
5,000 psi, and the resulting mixture was centrifuged for 1 h at 35,000
rpm in a Ti45 rotor (Beckman Coulter). The supernatant was incubated for
1.5 h at 4
 
 
 
C with 3 ml Ni-NTA agarose equilibrated in breaking buffer. The
beads were washed twice in breaking buffer containing 1% Triton X-100.
The beads were then extensively washed (
 
 
 
10 column vol) with buffer A
(25 mM Hepes · KOH, pH 7.4, 100 mM KCl, 5 mM 
 
 
 
-mercaptoethanol,
1% octyl-
 
 
 
-
 
D
 
-glucopyranoside (
 
 
 
OG), 10% glycerol) with 20 mM imida-
zole to remove nonspecifically bound proteins. Elution of the desired pro-
tein from the Ni-NTA beads was accomplished using a linear gradient from
20 mM to 1 M imidazole in buffer A.
For the expression of cd–Sytg I, BL21DE3 (Novagen) were transformed
with construct pLM7. Two 1-liter cultures of LB containing 50 
 
 
 
g/ml kana-
mycin were inoculated with 100 ml each of overnight precultures of trans-
formed cells (2   100 ml LB media containing 50  g/ml kanamycin). Cells
were grown to an OD (600 nm) of 0.6 and induced with 1 mM IPTG. After
3 h, cells were pelleted, washed with PBS, and resuspended in breaking
buffer containing protease inhibitor cocktail. Protein purification proce-
dures were the same as for Sytg I with the following exceptions: (a) no de-
tergent (Triton X-100 or  OG) was used and (b) the gradient was from 50
mM imidazole to 500 mM imidazole. Expression and purification of protein
from construct pLM8 was performed in an identical manner to cd–Sytg I.
Full-length t-SNARE complex (mouse his6-SNAP 25 and rat syntaxin 1A)
was expressed and purified from vector pTW34 as described previously
(Weber et al., 1998). Thrombin-cleavable (tc) t-SNARE complex (mouse
his6-SNAP 25 and tc-syntaxin 1A) was expressed and purified from vector
pTW69 as described previously (Parlati et al., 1999). Full-length mouse
VAMP-2 was expressed and purified from vector pTW2 as described previ-
ously (Weber et al., 1998).
Lipid mixtures
Donor lipid mix. Donor lipid mix contains 83.3 mol% 1-palmitoyl-2-ole-
oyl-SN-glycero-3-phosphatidylcholine (POPC), 15.1 mol% 1,2-dioleoyl-
SN-glycero-3-phosphatidylserine (DOPS), 0.8 mol% R-PE, 0.8 mol%
NBD-PE and trace amounts of [
3H]-DPPC, and 3 mM total lipid. 
Acceptor lipid mix. Acceptor lipid mix contains mol% POPC, 15 mol%
DOPS and trace [
3H]-DPPC, and 15 mM total lipid.
POPC only lipid mix (for lipid binding assay). POPC only lipid mix con-
tains 100 mol% POPC and trace amounts of [
3H]-DPPC, and 15 mM total
lipid. 
POPC/DOPS lipid mix (for lipid binding assay). POPC/DOPS lipid mix con-
tains 75 mol% POPC, 25 mol% DOPS and trace amounts of [
3H]-DPPC,
and 15 mM total lipid.
Protein reconstitution into liposomes and thrombin cleavage of 
t-SNARE liposomes
Liposomes were formed in the presence of VAMP 2 (0.7–1 mg/ml), Sytg I
(1 mg/ml), and t-SNARE (1.5–3 mg/ml) in various combinations using the
previously described technique of dilution and dialysis followed by a Ny-
codenz gradient (Weber et al., 1998) with the donor and acceptor lipid
mixes defined above. Note that for unlabeled v-SNARE liposomes, the
quantity of VAMP2 used was much lower (0.09 mg/ml). Protein amounts
in reconstituted liposomes were determined using Coomassie blue–stained
SDS-PAGE with protein standards and Quantity One Quantitation Soft-
ware (Bio-Rad Laboratories). The NH2-terminal domain of syntaxin was re-
moved by thrombin cleavage as described previously (Parlati et al., 1999).
Fusion assays
Fusion reactions and data analysis were performed as described previously
(Weber et al., 1998) with the following exceptions: (a) In all cases, 45  l of
acceptor (unlabeled) and 5  l of donor (labeled) liposomes were used, (b)
unless otherwise noted, both acceptor and donor liposomes were pre-
warmed to 37 C before mixing, and (c) to minimize quenching, 10 ml of
2.5% (wt/vol) dodecylmaltoside instead of Triton X-100 was added at the
end of the fusion reaction.
Lipid binding assay
For each vesicle preparation (POPC only or POPC/DOPS), 100  l of lipid
solution (see POPC only and POPC/DOPS lipid mixtures above) was
dried down in a 10   75 glass test tube by a stream of nitrogen, and trace
amounts of chloroform were removed under vacuum for 1 h. The dried
lipids were resuspended in 500 ml reconstitution buffer A (R buffer, 25
mm Hepes · KOH, pH 7.4), 100 mM KCl) and subjected to seven cycles
of freezing (liquid N2) and thawing (warm water). The lipid mixture was
then extruded through a 50 nm polycarbonate membrane using Liposo-
fast™-Basic (Avestin). The extruded liposomes were centrifuged at 25,000
rpm for 20 min in a Ti 100.3 (Beckman Coulter) rotor to pellet any aggre-
gates, and the liposome-rich supernatant was harvested and used for the
binding assay.
Sytg I beads or control beads were prepared by the immunoprecipita-
tion of Sytg I (110.6 mg) or buffer (control beads) with monoclonal anti-
body M48 (10  l, ascites fluid) and immobilization onto protein G beads
(100  l; Amersham Pharmacia Biotech) in the presence of R buffer. Beads
were diluted to give a final concentration of 20%.
For each sample, 50  l of 20% beads (Sytg I or control) were transferred
to a 1.5 ml Eppendorf tube, pelleted, and the supernatant was removed. To
these beads were added the appropriate liposomes (POPC only or POPC/
DOPS, 100,000 cpm,  1 mM final lipid concentration), EGTA (2 mM final
concentration), where appropriate calcium in the form of calcium chloride
(2.102 mM final concentration, 100  M effective concentration), and R
buffer to give a final volume of 100  l. The mixtures were incubated 30
min at RT with rotation. The beads were then pelleted, washed with 3   1 Synaptotagmin I accelerates SNARE-mediated fusion | Mahal et al. 281
ml R buffer (containing either 100  M EGTA-buffered calcium or 2 mM
EGTA as appropriate), and solubilized in 100  l 10% SDS solution. The
mixture was transferred to scintillation vials containing Scintiverse (10 ml;
Fischer), and the 
3H radioactivity was counted (5 min per vial; Beckman
Coulter LS6001C).
t-SNARE binding assay
Sytg I (107  g) was immobilized on protein A beads (100  l beads; Amer-
sham Pharmacia Biotech) by immunoprecipitation with monoclonal anti-
body CI.41.1 (10  l) in buffer T (20 mM Tris · HCl, pH 7.4, 150 mM NaCl,
0.5% Triton X-100) with 1 mg/ml BSA. The beads were diluted to give a fi-
nal concentration of 20%, split into two pools, and washed with buffer T
containing 1 mg/ml BSA and either 1 mM EGTA or 1 mM CaCl2 (Ca). Beads
were again diluted to 20% in the appropriate buffer. For each sample, 50  l
of 20% beads (Ca or EGTA) were transferred to a 1.5 ml Eppendorf tube,
and full-length t-SNARE complex (30  g) was added. Reaction volume was
adjusted to a final volume of 500  l (1  M final concentration t-SNARE).
The mixtures were incubated at 4 C for 1 h with shaking, pelleted, and
washed 3   1 ml with buffer T containing either Ca or EGTA. The beads
were then pelleted, supernatant was removed, and 15  l of 1   SDS PAGE
sample buffer (50 mM Tris · HCl, pH 6.8, 2% SDS, 0.1% bromphenol blue,
10% glycerol, 100 mM DTT) was added. Samples were heated at 95 C for
10 min and analyzed by SDS-PAGE. The experiment was also done using
cd–Sytg I and monoclonal antibody M48 in an identical manner.
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